|
Tue, 08/12/2025 - 06:33 |
Mumbai, August 12, 2025: Global Pharma major Lupin Limited (Lupin) today announced that it has partnered with Sandoz Group AG (Sandoz), Switzerland, to market and commercialize Lupins biosimilar ranibizumab across multiple regions. |
Lupin |
|
Mon, 05/26/2025 - 08:33 |
: Global Pharma major Lupin Limited (Lupin) today announced that it has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupins biosimilar ranibizumab across Lat |
Lupin |
|
Tue, 05/20/2025 - 15:39 |
Chugai Obtains First Regulatory Approval in Japan for Vabysmo for Additional Indication of Angioid Streaks, a Cause of Vision Loss |
Chugai |
|
Mon, 08/05/2024 - 21:27 |
India, USA, Europe, Russia, August 05, 2024: Global Pharma major Lupin Limited (Lupin) today announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar candidate to Lucentis. The study has achieved its primary endpoi |
Lupin |
|
Wed, 06/26/2024 - 13:11 |
New eye screening technology delivers hope to remote communities |
UWA |
|
Fri, 05/10/2024 - 21:27 |
Jose Cunha-Vaz Named 2024 Helen Keller Laureate by BrightFocus Foundation, Helen Keller Foundation for Research and Education |
BrightFocus Fou... |
|
Thu, 12/08/2022 - 10:13 |
ORAUs Ken Tobin selected as National Academy of Inventors Fellow |
Oak Ridge Assoc... |
|
Sat, 06/04/2022 - 13:30 |
CDC Study Finds Shift in Vision Impairment Trends Among Adults with Diabetes |
American Diabet... |
|
Mon, 05/02/2022 - 13:25 |
The American Diabetes Association, with Visionary Partners VSP Vision Care and Regeneron, to Address Barriers to Accessing Resources to Manage Ones Eye Health |
American Diabet... |
|
Mon, 01/31/2022 - 21:30 |
BrightFocus Foundation Response to FDA Approval of New Vision Treatment |
BrightFocus Fou... |
|
Sun, 09/26/2021 - 23:59 |
Study Suggests Youth Who Use Insulin Pumps Less at Risk for Diabetic Retinopathy |
Johns Hopkins H... |
|
Thu, 09/23/2021 - 00:11 |
Retinal Surgery Device Market, Impact of COVID-19, By Product, Companies, Forecast By 2027 - Renub Research |
Market-Research |
|
Mon, 09/13/2021 - 11:13 |
Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference |
Oncobiologics |
|
Mon, 08/09/2021 - 19:33 |
Premier Academy360 Offers New Diabetes-Focused Continuing Education Course for VSP Network Doctors Created in Partnership with the American Diabetes Association |
VSP Vision Care |
|
Wed, 08/04/2021 - 00:06 |
Illinois Tech Researcher Awarded $2.5 Million Grant to Prevent Vision Loss in Diabetes Patients |
Illinois Instit... |
|
Thu, 05/20/2021 - 01:48 |
American Diabetes Association, with Visionary Partners VSP Vision Care and Regeneron Launch The Next Step Eye Challenge Campaign for Healthy Vision Month in May |
American Diabet... |
|
Tue, 05/18/2021 - 11:34 |
Eyemart Express Shares 4-Step Wellness Plan for Healthy Vision Month |
VFW |
|
Wed, 05/12/2021 - 08:13 |
Outlook Therapeutics to Host Virtual Clinical Day on May 20, 2021 |
Oncobiologics |
|
Fri, 05/07/2021 - 12:17 |
/ LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema |
LumiThera |
|
Wed, 04/07/2021 - 16:51 |
Samsungs EYELIKE Fundus Camera Repurposes Galaxy Smartphones To Improve Access To Eye Care |
Samsung |
|
Wed, 03/31/2021 - 15:27 |
Outlook Therapeutics Reports Positive Safety Profile from NORSE THREE Open-Label Safety Study for ONS-5010 / LYTENAVA (bevacizumab-vikg) |
Oncobiologics |
|
Tue, 03/30/2021 - 17:00 |
Preventive treatment reduces diabetic retinopathy complications |
NIH |
|
Thu, 03/04/2021 - 18:27 |
Intel-Powered AI Solution Helps Reduce Diabetic Vision Loss |
Intel |
|
Mon, 02/15/2021 - 14:15 |
/ LumiThera listed as 1 of 10 Startups to Watch |
LumiThera |
|
Tue, 02/02/2021 - 03:12 |
Research Story Tip: Adult-Proven Smart Diagnostic Tool for Diabetic Retinopathy Also Works for Kids |
Johns Hopkins H... |
